Radius Health & Menarini Group Provide Elacestrant Update

Author's Avatar
Sep 25, 2020
Article's Main Image

Target enrollment milestone reached in the Phase 3 EMERALD study

Life cycle planning advancing in parallel with current Phase 3 monotherapy program

PR Newswire